Dopaminergic dysfunction in abstinent dexamphetamine users: Results from a pharmacological fMRI study using a reward anticipation task and a methylphenidate challenge

Drug and Alcohol Dependence

Volumn 130, Issue 1-3, 2013, Pages 52-60

  Schouw, M L J ^a   De Ruiter, M B ^a   Kaag, A M ^a   van den Brink, W ^a   Lindauer, R J L ^a   Reneman, L ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Dextro amphetamine; Dopamine; FMRI; Methylphenidate; Reward

Indexed keywords

DEXAMPHETAMINE; METHYLPHENIDATE;

ABSTINENCE; ADULT; ARTICLE; BRAIN FUNCTION; BRAIN TOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC DYSFUNCTION; DOPAMINERGIC SYSTEM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MALE; MONETARY INCENTIVE DELAY TASK; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RECREATION; REWARD; REWARD ANTICIPATION TASK;

ADULT; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHYLPHENIDATE; MOTIVATION; PHOTIC STIMULATION; PSYCHOMOTOR PERFORMANCE; REWARD; YOUNG ADULT;

PRIMATES; RODENTIA;

EID: 84877050227     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.10.010     Document Type: Article

References (62)

1. Ecstasy and the Dutch rave scene: a socio-epidemiological study on the nature and extent of, and the risks involved in using ecstasy and other party drugs at dance events 1998, Addiction Research Institute (US), University of Utrecht, Utrecht.
2. Asensio S., Romero M.J., Romero F.J., Wong C., Alia-Klein N., Tomasi D., Wang G.J., Telang F., Volkow N.D., Goldstein R.Z. Striatal dopamine D2 receptor availability predicts the thalamic and medial prefrontal responses to reward in cocaine abusers three years later. Synapse 2010, 64:397-402.
3. Beck A., Schlagenhauf F., Wustenberg T., Hein J., Kienast T., Kahnt T., Schmack K., Hagele C., Knutson B., Heinz A., Wrase J. Ventral striatal activation during reward anticipation correlates with impulsivity in alcoholics. Biol. Psychiatry 2009, 66:734-742.
4. Beckmann C.F., Jenkinson M., Smith S.M. General multilevel linear modeling for group analysis in fMRI. Neuroimage 2003, 20:1052-1063.
5. 11C]raclopride/positron emission tomography study in healthy men. Arch. Gen. Psychiatry 2006, 63:1386-1395.
6. Buckholtz J.W., Treadway M.T., Cowan R.L., Woodward N.D., Li R., Ansari M.S., Baldwin R.M., Schwartzman A.N., Shelby E.S., Smith C.E., Kessler R.M., Zald D.H. Dopaminergic network differences in human impulsivity. Science 2010, 329:532.
7. Bush G., Spencer T.J., Holmes J., Shin L.M., Valera E.M., Seidman L.J., Makris N., Surman C., Aleardi M., Mick E., Biederman J. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. Arch. Gen. Psychiatry 2008, 65:102-114.
8. Chen Y.I., Choi J.K., Jenkins B.G. Mapping interactions between dopamine and adenosine A2a receptors using pharmacologic MRI. Synapse 2005, 55:80-88.
9. Chen Y.I., Choi J.K., Xu H., Ren J., Andersen S.L., Jenkins B.G. Pharmacologic neuroimaging of the ontogeny of dopamine receptor function. Dev. Neurosci. 2010, 32:125-138.
10. Cole S.W., Yoo D.J., Knutson B. Interactivity and reward-related neural activation during a serious videogame. PLoS One 2012, 7:e33909.
11. Comings D.E., Blum K. Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog. Brain Res. 2000, 126:325-341.
12. de Win M.M., Jager G., Booij J., Reneman L., Schilt T., Lavini C., Olabarriaga S.D., Den Heeten G.J., van den Brink W. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain 2008, 131:2936-2945.
13. Dixon A.L., Prior M., Morris P.M., Shah Y.B., Joseph M.H., Young A.M. Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI. Neuropharmacology 2005, 48:236-245.
14. Ersche K.D., Fletcher P.C., Lewis S.J., Clark L., Stocks-Gee G., London M., Deakin J.B., Robbins T.W., Sahakian B.J. Abnormal frontal activations related to decision-making in current and former amphetamine and opiate dependent individuals. Psychopharmacology (Berl.) 2005, 180:612-623.
15. Ginovart N., Farde L., Halldin C., Swahn C.G. Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates. Synapse 1999, 31:154-162.
16. Haber S.N., Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 2010, 35:4-26.
17. Hahn T., Heinzel S., Dresler T., Plichta M.M., Renner T.J., Markulin F., Jakob P.M., Lesch K.P., Fallgatter A.J. Association between reward-related activation in the ventral striatum and trait reward sensitivity is moderated by dopamine transporter genotype. Hum. Brain Mapp. 2011, 32:1557-1565.
18. Hommer D.W., Bjork J.M., Gilman J.M. Imaging brain response to reward in addictive disorders. Ann. N.Y. Acad. Sci. 2011, 1216:50-61.
19. Honey G., Bullmore E. Human pharmacological MRI. Trends Pharmacol. Sci. 2004, 25:366-374.
20. Jacobs B.L., Heym J., Trulson M.E. Cats develop tolerance to d-amphetamine's effects upon locomotion and stereotyped behaviors. Eur. J. Pharmacol. 1981, 69:353-356.
21. Jenkinson M., Bannister P., Brady M., Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002, 17:825-841.
22. Jia Z., Worhunsky P.D., Carroll K.M., Rounsaville B.J., Stevens M.C., Pearlson G.D., Potenza M.N. An initial study of neural responses to monetary incentives as related to treatment outcome in cocaine dependence. Biol. Psychiatry 2011, 70:553-560.
23. Katusic S.K., Barbaresi W.J., Colligan R.C., Weaver A.L., Leibson C.L., Jacobsen S.J. Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population-based, birth cohort study. J. Child Adolesc. Psychopharmacol. 2005, 15:764-776.
24. Knutson B., Adams C.M., Fong G.W., Hommer D. Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J. Neurosci. 2001, 21:RC159.
25. Knutson B., Bjork J.M., Fong G.W., Hommer D., Mattay V.S., Weinberger D.R. Amphetamine modulates human incentive processing. Neuron 2004, 43:261-269.
26. Kuczenski R., Segal D.S. An escalating dose/multiple high-dose binge pattern of amphetamine administration results in differential changes in the extracellular dopamine response profiles in caudate-putamen and nucleus accumbens. J. Neurosci. 1997, 17:4441-4447.
27. Liddle E.B., Hollis C., Batty M.J., Groom M.J., Totman J.J., Liotti M., Scerif G., Liddle P.F. Task-related default mode network modulation and inhibitory control in ADHD: effects of motivation and methylphenidate. J. Child Psychol. Psychiatry 2011, 52:761-771.
28. Luman M., Oosterlaan J., Sergeant J.A. The impact of reinforcement contingencies on AD/HD: a review and theoretical appraisal. Clin. Psychol. Rev. 2005, 25:183-213.
29. 18F]fluoro-l-DOPA-PET studies show partial reversibility of long-term effects of chronic amphetamine in monkeys. Synapse 1996, 22:63-69.
30. Melega W.P., Raleigh M.J., Stout D.B., Lacan G., Huang S.C., Phelps M.E. Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey. Brain Res. 1997, 766:113-120.
31. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptors: from structure to function. Physiol. Rev. 1998, 78:189-225.
32. Ornstein T.J., Iddon J.L., Baldacchino A.M., Sahakian B.J., London M., Everitt B.J., Robbins T.W. Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology 2000, 23:113-126.
33. Peters J., Bromberg U., Schneider S., Brassen S., Menz M., Banaschewski T., Conrod P.J., Flor H., Gallinat J., Garavan H., Heinz A., Itterman B., Lathrop M., Martinot J.L., Paus T., Poline J.B., Robbins T.W., Rietschel M., Smolka M., Strohle A., Struve M., Loth E., Schumann G., Buchel C. Lower ventral striatal activation during reward anticipation in adolescent smokers. Am. J. Psychiatry 2011, 168:540-549.
34. Plichta M.M., Vasic N., Wolf R.C., Lesch K.P., Brummer D., Jacob C., Fallgatter A.J., Gron G. Neural hyporesponsiveness and hyperresponsiveness during immediate and delayed reward processing in adult attention-deficit/hyperactivity disorder. Biol. Psychiatry 2009, 65:7-14.
35. Rapeli P., Kivisaari R., Kahkonen S., Puuskari V., Autti T., Kalska H. Do individuals with former amphetamine dependence have cognitive deficits?. Nord. J. Psychiatry 2005, 59:293-297.
36. 123I]beta-CIT SPECT study-preliminary report. Psychopharmacology (Berl.) 2002, 159:335-340.
37. Ricaurte G.A., Mechan A.O., Yuan J., Hatzidimitriou G., Xie T., Mayne A.H., McCann U.D. Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates. J. Pharmacol. Exp. Ther. 2005, 315:91-98.
38. Ricaurte G.A., Seiden L.S., Schuster C.R. Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers. Brain Res. 1984, 303:359-364.
39. Rubia K., Halari R., Cubillo A., Mohammad A.M., Brammer M., Taylor E. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naive children with ADHD during a rewarded continuous performance task. Neuropharmacology 2009, 57:640-652.
40. Scheres A., Lee A., Sumiya M. Temporal reward discounting and ADHD: task and symptom specific effects. J. Neural Transm. 2008, 115:221-226.
41. Schlosser R.G., Nenadic I., Wagner G., Zysset S., Koch K., Sauer H. Dopaminergic modulation of brain systems subserving decision making under uncertainty: a study with fMRI and methylphenidate challenge. Synapse 2009, 63:429-442.
42. Schultz W. Getting formal with dopamine and reward. Neuron 2002, 36:241-263.
43. Segal D.S., Kuczenski R. Behavioral alterations induced by an escalating dose-binge pattern of cocaine administration. Behav. Brain Res. 1997, 88:251-260.
44. Shafritz K.M., Marchione K.E., Gore J.C., Shaywitz S.E., Shaywitz B.A. The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder. Am. J. Psychiatry 2004, 161:1990-1997.
45. Shiels K., Hawk L.W., Reynolds B., Mazzullo R.J., Rhodes J.D., Pelham W.E., Waxmonsky J.G., Gangloff B.P. Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder. Exp. Clin. Psychopharmacol. 2009, 17:291-301.
46. Smith S.M. Fast robust automated brain extraction. Hum. Brain Mapp. 2002, 17:143-155.
47. Spencer T.J., Biederman J., Madras B.K., Faraone S.V., Dougherty D.D., Bonab A.A., Fischman A.J. In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter. Biol. Psychiatry 2005, 57:1293-1300.
48. Stoy M., Schlagenhauf F., Schlochtermeier L., Wrase J., Knutson B., Lehmkuhl U., Huss M., Heinz A., Strohle A. Reward processing in male adults with childhood ADHD-a comparison between drug-naive and methylphenidate-treated subjects. Psychopharmacology (Berl.) 2011, 215:467-481.
49. Strakowski S.M., Sax K.W., Setters M.J., Keck P.E. Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans. Biol. Psychiatry 1996, 40:872-880.
50. Strohle A., Stoy M., Wrase J., Schwarzer S., Schlagenhauf F., Huss M., Hein J., Nedderhut A., Neumann B., Gregor A., Juckel G., Knutson B., Lehmkuhl U., Bauer M., Heinz A. Reward anticipation and outcomes in adult males with attention-deficit/hyperactivity disorder. Neuroimage 2008, 39:966-972.
51. Swanson J.M., Volkow N.D. Serum and brain concentrations of methylphenidate: implications for use and abuse. Neurosci. Biobehav. Rev. 2003, 27:615-621.
52. Tilley M.R., Gu H.H. The effects of methylphenidate on knockin mice with a methylphenidate-resistant dopamine transporter. J. Pharmacol. Exp. Ther. 2008, 327:554-560.
53. Vaidya C.J., Austin G., Kirkorian G., Ridlehuber H.W., Desmond J.E., Glover G.H., Gabrieli J.D. Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:14494-14499.
54. Van den Heuvel D.M., Pasterkamp R.J. Getting connected in the dopamine system. Prog. Neurobiol. 2008, 85:75-93.
55. Volkow N.D., Wang G.J., Fowler J.S., Tomasi D., Telang F. Addiction: beyond dopamine reward circuitry. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:15037-15042.
56. Volkow N.D., Wang G.J., Kollins S.H., Wigal T.L., Newcorn J.H., Telang F., Fowler J.S., Zhu W., Logan J., Ma Y., Pradhan K., Wong C., Swanson J.M. Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA 2009, 302:1084-1091.
57. Volkow N.D., Wang G.J., Ma Y., Fowler J.S., Wong C., Jayne M., Telang F., Swanson J.M. Effects of expectation on the brain metabolic responses to methylphenidate and to its placebo in non-drug abusing subjects. Neuroimage 2006, 32:1782-1792.
58. Wilens T.E. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr. Clin. North Am. 2004, 27:283-301.
59. Wilens T.E., Adler L.A., Adams J., Sgambati S., Rotrosen J., Sawtelle R., Utzinger L., Fusillo S. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J. Am. Acad. Child Adolesc. Psychiatry 2008, 47:21-31.
60. Wilkison P.C., Kircher J.C., McMahon W.M., Sloane H.N. Effects of methylphenidate on reward strength in boys with attention-deficit hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 1995, 34:897-901.
61. Willson M.C., Wilman A.H., Bell E.C., Asghar S.J., Silverstone P.H. Dextroamphetamine causes a change in regional brain activity in vivo during cognitive tasks: a functional magnetic resonance imaging study of blood oxygen level-dependent response. Biol. Psychiatry 2004, 56:284-291.
62. Wrase J., Schlagenhauf F., Kienast T., Wustenberg T., Bermpohl F., Kahnt T., Beck A., Strohle A., Juckel G., Knutson B., Heinz A. Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. Neuroimage 2007, 35:787-794.